1272758-04-9 Usage
Uses
Used in Medicinal Chemistry:
1-BOC-7-(3-ethoxy-3-oxopropyl)-3,4-dihydro-1,8-naphthyridine is used as a key intermediate in the synthesis of pharmaceutical drugs for its potential to contribute to the development of novel therapeutic agents. Its unique structure and the presence of the BOC protecting group make it a versatile component in the creation of bioactive molecules.
Used in Organic Synthesis:
In the field of organic synthesis, 1-BOC-7-(3-ethoxy-3-oxopropyl)-3,4-dihydro-1,8-naphthyridine serves as a valuable building block for the assembly of more complex organic molecules. The BOC group can be selectively removed under mild conditions, allowing for further functionalization and the construction of a variety of chemical entities with different properties and applications.
Used in Drug Discovery:
1-BOC-7-(3-ethoxy-3-oxopropyl)-3,4-dihydro-1,8-naphthyridine is utilized in drug discovery processes to explore its biological activity and evaluate its potential as a lead compound for the treatment of various diseases. 1-BOC-7-(3-ETHOXY-3-OXOPROPYL)-3,4-DIHYDRO-1,8-NAPHTHYRIDINE's structure may offer unique interactions with biological targets, leading to the discovery of new pharmacological agents.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 1-BOC-7-(3-ethoxy-3-oxopropyl)-3,4-dihydro-1,8-naphthyridine is employed as a component in the formulation of new drugs. Its properties may contribute to improved drug delivery, enhanced stability, or increased bioavailability, making it a valuable asset in the development of innovative therapeutics.
The specific applications and uses of 1-BOC-7-(3-ethoxy-3-oxopropyl)-3,4-dihydro-1,8-naphthyridine will depend on ongoing research and development, as well as the outcomes of further testing and validation in various scientific and industrial contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 1272758-04-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,2,7,5 and 8 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1272758-04:
(9*1)+(8*2)+(7*7)+(6*2)+(5*7)+(4*5)+(3*8)+(2*0)+(1*4)=169
169 % 10 = 9
So 1272758-04-9 is a valid CAS Registry Number.
1272758-04-9Relevant academic research and scientific papers
AMINO ACID COMPOUNDS AND METHODS OF USE
-
Paragraph 0588; 0591, (2020/04/29)
The invention relates to compounds of formula (I): or a salt thereof, wherein R1, G, L1, L2, L3, and Y are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are inhibitors of one, or both of, αvβ1 integrin and αvβ6 integrin that are useful for treating fibrosis such as in nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS
-
Page/Page column 84; 85, (2018/05/27)
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds are antagonists to αv- containing integrins. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with dysregulation of av-containing integrins, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE
-
Paragraph 0585; 0586, (2018/03/28)
The invention relates to compounds of formula (I), or a salt thereof wherein R1, A, L, and R2 and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are ανβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.
